QYO
- Product code
- QYO
- Device name
- Hematopoietic Cell Enrichment Kit
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.6120
- Medical specialty
- Immunology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 0 (direct download)
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
A hematopoietic cell enrichment kit is an in vitro diagnostic device intended for the selection and enrichment of specific hematopoietic cells from human whole blood and/or bone marrow collected from patients with hematological malignancies using immunomagnetic bead-based selection. It is intended for use with diagnostic assays as part of the pre-analytical workflow.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| DEN220090 | 2023-11-06 | Stemcell Technologies Canada, Inc. | EasySep Human Bone Marrow CD138 Positive Selection … | — |
Official FDA classification page: QYO
Classification and pathway per current FDA publications. Data from openFDA (CC0).